BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8060800)

  • 1. Reflux oesophagitis and its treatment.
    Long RG
    Br J Clin Pract Suppl; 1994; 75():36-9; discussion 40. PubMed ID: 8060800
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical review of lansoprazole.
    Lockhart SP
    Br J Clin Pract Suppl; 1994; 75():48-55; discussion 56-7. PubMed ID: 8060802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M; Harford WV; Fisher RS; Sampliner RE; Murray SB; Greski-Rose PA; Jennings DE
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lansoprazol].
    Ponce J; Nos P
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract]   [Full Text] [Related]  

  • 5. Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.
    Berstad A; Hatlebakk JG
    Aliment Pharmacol Ther; 1993; 7 Suppl 1():34-6, discussion 61-6. PubMed ID: 8490077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole versus omeprazole in the treatment of reflux esophagitis.
    Vcev A; Stimac D; Vceva A; Rubinić M; Ivandić A; Ivanis N; Horvat D; Volarić M; Karner I
    Acta Med Croatica; 1997; 51(3):171-4. PubMed ID: 9248117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lansoprazole--a new proton pump inhibitor.
    Ahmed W; Ali A; Qureshi H; Zuberi SJ; Shamsi ZU
    J Pak Med Assoc; 1995 May; 45(5):144-5. PubMed ID: 7563582
    [No Abstract]   [Full Text] [Related]  

  • 8. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of omeprazole and ranitidine in the treatment of reflux esophagitis.
    Blum AL; Riecken EO; Dammann HG; Schiessel R; Lux G; Wienbeck M; Rehner M; Witzel L
    N Engl J Med; 1986 Mar; 314(11):716. PubMed ID: 3513011
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short-term therapy. Preliminary report].
    Córdova-Villalobos JA; Ramírez-Barba EJ; Ramírez-Covarrubias JC
    Rev Gastroenterol Mex; 1996; 61(4):306-9. PubMed ID: 9072780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM
    Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ].
    Cherniakevich SA; Babkova IV; Mikhalev AI
    Klin Med (Mosk); 2002; 80(9):52-4. PubMed ID: 12416227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group.
    Bardhan KD; Hawkey CJ; Long RG; Morgan AG; Wormsley KG; Moules IK; Brocklebank D
    Aliment Pharmacol Ther; 1995 Apr; 9(2):145-51. PubMed ID: 7605854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proton pump inhibitors in the treatment of reflux esophagitis].
    Bigard MA
    Rev Prat; 1994 Oct; 44(15):1992-6. PubMed ID: 7984887
    [No Abstract]   [Full Text] [Related]  

  • 16. Ranitidine vs metoclopramide in the medical treatment of reflux esophagitis.
    Guslandi M; Testoni PA; Passaretti S; Masci E; Ballarin E; Comin U; Marchi R; Ronchi G; Tittobello A
    Hepatogastroenterology; 1983 Jun; 30(3):96-8. PubMed ID: 6309637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole].
    Müller P; Fuchs W; Peifer-Weiss A; Simon B
    Fortschr Med; 1998 Oct; 116(28):31-2. PubMed ID: 9844264
    [No Abstract]   [Full Text] [Related]  

  • 19. [A randomized, comparative study of rabeprazole vs. ranitidine maintenance therapies for reflux esophagitis--multicenter study].
    Jee SR; Seol SY; Kim DH; Park SJ; Han SY; Urm SH; Lee JT
    Korean J Gastroenterol; 2005 May; 45(5):321-7. PubMed ID: 15908764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
    Lambert R
    J Gastroenterol Hepatol; 1996 Oct; 11(10):897-9. PubMed ID: 8912122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.